A male neonate was born at 37 weeks' gestation to a 21-year-old African American woman following a pregnancy complicated by a flu-like illness 3 weeks prior to delivery. Maternal prenatal laboratory evaluation revealed an O-negative blood type, negative serological results for hepatitis B, syphilis, and human immunodeficiency virus, and immunity to rubella.
On examination, the infant's weight, height, and head circumference were at the fifth percentile for gestational age. Skin examination revealed violaceous maculopapular lesions and petechiae over the face (Figure 1), trunk (Figure 2), and extremities. Physical examination was also notable for bilateral conjunctival hemorrhages and palpable hepatosplenomegaly.
Violaceous macules and papules involving the face and trunk.
Similar violaceous macules and papules observed on the trunk, buttocks, and leg.
Laboratory investigation showed a hematocrit of 40% (reference range, 41%-65%), a platelet count of 42 000/μL (reference range, 150 000-450 000/μL), and a leukocyte count of 16 300/μL (reference range, 9400-34 000/μL) with 12% polymorphonuclear cells, 73% lymphocytes, and 9% monocytes. The prothrombin time was greater than 2 minutes (reference range, 12-23.5 seconds), and the partial thromboplastin time was 119 seconds (reference range, 35-52 seconds). The aspartate aminotransferase level was 338 IU/L (reference range, 14-70 IU/L; to convert to microkatals per liter, multiply by 0.0167); the alanine aminotransferase level was 52 IU/L (reference range, < 54 IU/L; to convert to microkatals per liter, multiply by 0.0167). The total and direct bilirubin levels were 3.9 mg/dL and 2.1 mg/dL, respectively (reference ranges, 2-6 mg/dL and < 0.5 mg/dL, respectively; to convert to micromoles per liter, multiply by 17.104). Head ultrasonography demonstrated bilateral calcification of the thalamic vessels (Figure 3) and right-sided intraparenchymal and intraventricular hemorrhage.
Calcification of thalamic vessels (arrows) seen on a midsagittal view on head ultrasonography.
What is your diagnosis?
Thank you for submitting a comment on this article. It will be reviewed by JAMA Pediatrics editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
The Rational Clinical Examination
Evidence Summary and Review 2
The Rational Clinical Examination
Location of Paracentesis and Ultrasound Guidance
All results at
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.